Feasibility Study of a Post-hospitalization Self-rehabilitation Program for Elderly Suffering of Sarcopenia (FREESARC)

February 6, 2019 updated by: Institut Mutualiste Montsouris

Loss of autonomy among elderly during and after hospitalisation is a well-known problem. Patient suffering of sarcopenia (decreasing in muscle mass and function) are more likely not to recover their previous autonomy.

Studies have shown that physical exercise, especially resistance exercises, is the most efficient known treatment of sarcopenia. Several institution-based rehabilitation programs had been implemented in this purpose.

On the other hand, some studies have shown that home-based self-rehabilitation can be as efficient as institution-based rehabilitation, for example in stroke, cardiac failure and COPD rehabilitation.

The investigators propose to set up a home-based self-rehabilitation program to fight against sarcopenia and hence increasing autonomy among elderly. This study aimed to establish the feasibility of such a program.

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Paris, France, 75014
        • Recruiting
        • Institut Mutualiste Montsouris
        • Contact:
        • Contact:
        • Principal Investigator:
          • Martine GAYRAUD LARMIGNAT, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients aged 70 or older
  • Non-institutionnalised patients
  • Patients suffering of sarcopenia during hospitalisation (assessed by the Short Physical Performance Battery, Bio-Impedance analysis and griptest)
  • Patients hospitalised in the service of Internal Medicine of Institut Mutualiste Montsouris
  • Patients returning at home after hospitalisation
  • Patients who gave their written consent
  • Patients who benefits from a social security coverage

Exclusion Criteria:

  • Patients suffering from a severe medical condition not allowing them to follow a physical exercise program
  • Palliative care patients
  • Patients without the musculo-squelettic capacity to follow the program : 4/4 on seated postural stability scale ; no motor deficit on lower limb muscular testing ; quadricipital locking when standing
  • Patients with severe cognitive disorders (according to MMSE score adapted to socio-cultural level and age)
  • Patients who live more than 150 km away
  • Patients following specific physiotherapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Arm 1: Self-rehabilitation arm
Self-rehabilitation arm

Participants follow a home-based self-rehabilitation program consisting of the realisation of a set of physical exercises using an elastic band. The exercises have to be performed 3 times a week, and are associated with a protein supplementation.

The rehabilitation follow-up by the physician is planned once a week, by phone, and with face-to-face appointments at inclusion, 6 weeks and 3 months follow-up.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasability of a post-hospitalization self-rehabilitation program for sarcopenic elderly patients
Time Frame: 3 months
Measured from program adherence using a patient notebook
3 months
Feasability of a post-hospitalization self-rehabilitation program for sarcopenic elderly patients
Time Frame: 3 months
Measured from patient satisfaction using a satisfaction scale
3 months
Feasability of a post-hospitalization self-rehabilitation program for sarcopenic elderly patients
Time Frame: 3 months
Measured from medical time required by phone call
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscular status evaluation
Time Frame: 3 months
Change in muscle mass measured with Bio-Impedance analysis
3 months
Muscular status evaluation
Time Frame: 3 months
Performance in muscle mass measured with Short Physical Performance Battery
3 months
Muscular status evaluation
Time Frame: 3 months
Force in muscle mass measured with Grip test
3 months
Autonomy degree evaluation
Time Frame: 3 months
Change in autonomy measured with Barthel Index
3 months
Quality of life evaluation
Time Frame: 3 months
Change in quality of life measured with Médical Outcomes Study Short Form 36
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 9, 2018

Primary Completion (Anticipated)

March 1, 2019

Study Completion (Anticipated)

June 1, 2019

Study Registration Dates

First Submitted

January 21, 2019

First Submitted That Met QC Criteria

February 6, 2019

First Posted (Actual)

February 7, 2019

Study Record Updates

Last Update Posted (Actual)

February 7, 2019

Last Update Submitted That Met QC Criteria

February 6, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sarcopenia

Clinical Trials on Self-rehabilitation program and protein supplement

3
Subscribe